Published: May 2022 | Report Code: 12317 | Available Format: PDF
The global cardiac monitoring market size stood at $7,965.7 million in 2021, which is expected to reach $16,124.0 million by 2030, at a CAGR of 8.2% during 2021–2030. This is ascribed to the rising prevalence of CVDs, which, as per WHO, are the leading cause of death around the world, with a mortality of 17.9 million every year.
Factors that directly affect heart health include high tobacco use, high cholesterol levels, obesity, physical inactivity, diabetes, poor diet, and alcohol use. Due to the changes in lifestyle, continuous monitoring of cardiac health is required; therefore, medical technology companies are launching various products. For instance, in November 2021, Biotricity Inc. unveiled Bioheart, a direct-to-consumer heart monitor that enables 24/7 continuous rhythm monitoring for 48 hours on a full battery.
Pre-monitoring and pre-diagnosis can prevent the majority of CVDs. Atrial fibrillation (AFib) is the most-common arrhythmia diagnosed in clinical practice. The prevalence of AFib was around 6.1 million cases in the U.S. in 2021, which is projected to increase to 12.1 million cases in 2030. Arrhythmias can be prevented with early detection; consequently, the demand for cardiac monitoring and cardiac rhythm management devices is rising, as they save the lives of patients who are at a high risk of cardiac arrest.
With new developments in heart monitoring devices, notably mobile cardiac telemetry (MCT) systems, cardiac monitoring practices have substantially improved. For instance, in February 2021, RhythMedix LLC launched its next-generation RhythmStar wearable device with built-in 4G cellular connectivity. The novel cardiac telemetry monitor is designed for extended and accurate assessment of cardiac rhythm in real time, without the need for a phone or any other communication device.
Moreover, the rising adoption of digital health services intensifies the cardiac monitoring market growth. As per the Future Health Index Report 2020 by Koninklijke Philips N.V., emerging economies are leading the way in the adoption of digital health technologies. For instance, in the U.A.E. and China, 46% and 58% of the patients share data with healthcare professionals via connected devices, respectively. In contrast, in Sweden, Germany, and the U.K., the percentage is around 17%, 12%, and 26%, respectively.
2read ECGs is intensifying the market growth. In July 2021, the FDA approved two AI algorithms of Medtronic for use with the LINQ II insertable cardiac monitor. The AccuRhythm AI algorithms use AI to enhance the precision and accuracy of the heart rhythm event data captured using LINQ II.
Moreover, in February 2022, AliveCor Inc. announced the launch of the KardiaMobile Card, a slim and convenient personal ECG device. The size of a credit card, it performs a single-lead ECG in 30 seconds. It pairs with a smartphone using the Bluetooth technology, to detect six of the most-common arrhythmias.
Additionally, in June 2019, Infobionic launched the MoMe Kardia monitoring system, a non-invasive remote cardiac monitor, to provide complete heart rate data over the cloud.
The resting ECG category accounted for around 38% revenue share in 2021. This is attributed to the quick and enhanced diagnosis of cardiac health via these devices in comparison to other short- & longer-term monitoring devices. Additionally, the costs associated with resting ECG devices are comparatively lower as compared to others. Moreover, these instruments can be used with numerous other cardiac diagnostic tests, telemetry monitoring equipment, and in medical procedures.
Hospitals generated around $3,070.3 million revenue in 2021, and this number will grow at a CAGR of 7.8% during 2021–2030. Their high revenue contribution is due to the rising prevalence of CVDs, surging number of patient visits to hospitals, rising number of cardiac device implantation procedures, and easy availability of reimbursement for these procedures. Around 6.9% of the patients who suffer from ischemic heart disease, coronary artery disease, or a history of myocardial infarction visit hospitals in the U.S. every year, while around 7.2% of the patients with heart diseases visit emergency departments.
The North American cardiac monitoring market was valued at an estimated $2,998.3 million in 2021, and it is expected to advance at a CAGR of 8.7% during 2021–2030. The major share of the region is on account of the rising prevalence of CVDs, increasing healthcare expenditure, mounting disposable income, growing healthcare awareness, and the availability of technologically advanced devices. Around 4.6% of the U.S. adults were diagnosed with coronary heart disease in 2020.
Report Attribute | Details |
Historical Years |
2017-2021 |
Forecast Years |
2022-2030 |
Market Size in 2021 |
$7,965.7 Million |
Revenue Forecast in 2030 |
$16,124 Million |
Growth Rate |
8.2% CAGR |
Report Scope |
Market Trends, Drivers, and Restraints; Revenue Estimation and Forecast; Segmentation Analysis; Regulatory Scenario; Impact of COVID-19; Companies’ Strategic Developments; Market Share Analysis of Key Players; Company Profiling |
Segments Covered |
By Product; By Mode; By End User; By Region |
Explore more about this report - Request free sample pages
In recent years, players in the cardiac monitoring market have been involved in product launches and acquisitions to attain a significant position. For instance,
The research offers the market size of the global cardiac monitoring market for the period 2017–2030.
Based on Product
Based on Mode
Based on End User
Geographical Analysis
In 2021, the market for cardiac monitoring solutions valued $7,965.7 million.
The cardiac monitoring industry will have a CAGR of 8.2% during 2021–2030.
The COVID-19 pandemic had a positive effect on the market for cardiac monitoring solutions.
Governments are driving the cardiac monitoring industry by allowing for easy reimbursement for cardiovascular procedures and rapidly approving new heart rhythm monitoring devices.
North America dominates the market for cardiac monitoring solutions.
Get a bespoke market intelligence solution
Want a report tailored exactly to your business strategy?
Request CustomizationWant an insight-rich discussion with the report author?
Speak to AnalystOur dedication to providing the most-accurate market information has earned us verification by Dun & Bradstreet (D&B). We strive for quality checking of the highest level to enable data-driven decision making for you
Our insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights
With 24/7 research support, we ensure that the wheels of your business never stop turning. Don’t let time stand in your way. Get all your queries answered with a simple phone call or email, as and when required
We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws